Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $716878.0.

  • iSpecimen's Accumulated Expenses fell 2988.1% to $716878.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $716878.0, marking a year-over-year decrease of 2988.1%. This contributed to the annual value of $1.2 million for FY2024, which is 2413.47% down from last year.
  • iSpecimen's Accumulated Expenses amounted to $716878.0 in Q3 2025, which was down 2988.1% from $645567.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Accumulated Expenses ranged from a high of $1.9 million in Q2 2021 and a low of $634256.0 during Q2 2022
  • Over the past 5 years, iSpecimen's median Accumulated Expenses value was $1.0 million (recorded in 2021), while the average stood at $1.1 million.
  • As far as peak fluctuations go, iSpecimen's Accumulated Expenses crashed by 7268.55% in 2021, and later soared by 8835.1% in 2024.
  • Quarter analysis of 5 years shows iSpecimen's Accumulated Expenses stood at $1.0 million in 2021, then soared by 51.64% to $1.5 million in 2022, then increased by 0.61% to $1.5 million in 2023, then decreased by 24.13% to $1.2 million in 2024, then plummeted by 38.66% to $716878.0 in 2025.
  • Its Accumulated Expenses was $716878.0 in Q3 2025, compared to $645567.0 in Q2 2025 and $818254.0 in Q1 2025.